Optimising General Public Uptake of a Covid-19 Vaccine: A Mixed Methods Study (OPTIMUM)

优化公众对 Covid-19 疫苗的吸收：混合方法研究 (OPTIMUM)

• 批准号: ES/V012851/1
• 负责人: Martine Stead
• 金额: $ 36.57万
• 依托单位: University of Stirling
• 依托单位国家: 英国
• 项目类别: Research Grant
• 财政年份: 2020
• 资助国家: 英国
• 起止时间: 2020 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=ES%2FV012851%2F1
• 关键词: Optimising; General; Public; Uptake; Covid

The Covid-19 pandemic of 2020 has disrupted people's daily lives in many parts of the world, including in the UK, and it has caused many people to become ill and even die. Scientists, policy makers and the general public hope that a Covid-19 vaccine will developed soon, to help to prevent the spread of Covid-19 in future. As with any vaccination, it is very important that the public are confident in the vaccine so that most people will want to choose to have the vaccine. A high uptake of the vaccine is needed to protect as many individuals from becoming ill as possible, and to stop the spread of the virus. Recent studies suggest most people want a vaccine, but a minority of people are uncertain about whether they would want to be vaccinated against Covid-19. This seems to be because some people are worried about the safety of a new vaccine or do not have trust in the benefits of vaccination more generally.We want to understand more about what people see as the upsides and downsides of a new Covid-19 vaccine. This information will help to design a vaccination campaign that is trusted by people because it tells them what they want to - or need to - know before making a decision about having the vaccination. A good vaccination campaign would help to increase vaccine uptake, and help people separate facts about the vaccine from misinformed stories. To understand what hopes and worries people have about a Covid-19 vaccine, we plan to do a study on people's attitudes towards a new Covid-19 vaccine. The study will have four parts.In the first part, we will interview 12-15 key people involved in vaccine policy and in providing vaccines in different parts of the UK. The interviews will ask about: plans for vaccine roll-out; expected barriers and facilitators to vaccine uptake; communication challenges; key messages, channels and target groups, including professional and public; and any helfpul learning from other countries and other campaigns.In the second part, we will ask a sample of around 2,250 adults in the general population across Great Britain to take part in a survey about Covid-19 and a vaccine to prevent it. The people we ask will be a random sample of people who have taken part in the British Social Attitudes Survey in the past. The survey will include questions in five key ares: (1) typical behaviour in the past for other vaccines (e.g. annual flu vaccination, childhood vaccination); (2) general attitudes to vaccination; (3) experience of Covid-19 infection and whether people feel they are likely to get Covid-19 in the future (e.g. tested positive, suspected infection, contact with people with Covid-19 through their work, being in some of the groups that were asked to 'shield'); (4) attitudes and beliefs towards a new Covid-19 vaccine (e.g. safety, effectiveness, accessibility, necessity, trust, sources of information about vaccination, responsibility to others); and (5) people's intentions (e.g. whether they think they would agree to be vaccinated). Participants will also be asked about views and use of the NHS Tracking App.In the third part, will will invite a smaller sample of about 30 people, including some people at higher risk of Covid-19, to take part in more in-depth interviews so that we can understand their hopes and concerns about the development and roll-out of a Covid-19 vaccine in much more detail. In the last part of the study, we will go back to key people involved in vaccine policy and in providing vaccines in different parts of the UK and invite them to workshops so that they can hear about the study findings and use these to shape their information and plans to support high uptake of the vaccine.

2020年新冠肺炎疫情在包括英国在内的世界许多地方扰乱了人们的日常生活，导致许多人生病甚至死亡。科学家、政策制定者和公众希望尽快开发出Covid-19疫苗，以帮助防止Covid-19在未来的传播。与任何疫苗接种一样，公众对疫苗有信心是非常重要的，这样大多数人才会选择接种疫苗。为了保护尽可能多的人不生病，并阻止病毒的传播，需要高度接种疫苗。最近的研究表明，大多数人都想接种疫苗，但少数人不确定他们是否想接种Covid-19疫苗。这似乎是因为有些人担心新疫苗的安全性，或者不相信接种疫苗的好处。我们想更多地了解人们认为新的Covid-19疫苗的优点和缺点。这些信息将有助于设计一个人们信任的疫苗接种运动，因为它告诉他们在决定是否接种疫苗之前他们想要或需要知道什么。良好的疫苗接种运动将有助于提高疫苗的吸收率，并帮助人们将有关疫苗的事实与错误的报道区分开来。为了了解人们对新冠疫苗的希望和担忧，我们计划进行一项关于人们对新冠疫苗态度的研究。研究将分为四个部分。在第一部分中，我们将采访12-15名参与疫苗政策和在英国不同地区提供疫苗的关键人物。访谈将涉及以下问题：疫苗推广计划；疫苗接种的预期障碍和促进因素；沟通困难,关键信息、渠道和目标群体，包括专业人士和公众；从其他国家和其他运动中学到什么有用的东西。在第二部分中，我们将要求英国普通人群中约2250名成年人参加一项关于Covid-19和预防疫苗的调查。我们所询问的人将是过去参加过英国社会态度调查的人的随机样本。调查将包括五个关键领域的问题：(1)过去接种其他疫苗的典型行为（例如每年接种流感疫苗，儿童接种疫苗）；(2)对疫苗接种的一般态度；(3)有过Covid-19感染经历，以及人们是否觉得自己有可能在未来感染Covid-19（例如，检测呈阳性、疑似感染、在工作中接触过Covid-19患者、在一些被要求“屏蔽”的群体中）；(4)对新型Covid-19疫苗的态度和信念（如安全性、有效性、可及性、必要性、信任、疫苗接种信息来源、对他人的责任）；(5)人们的意图（例如，他们是否认为他们会同意接种疫苗）。参与者还将被问及对NHS跟踪应用程序的看法和使用情况。第三部分将邀请大约30人的小样本，包括一些感染Covid-19风险较高的人，参加更深入的访谈，以便我们能够更详细地了解他们对开发和推出Covid-19疫苗的希望和担忧。在研究的最后一部分，我们将回到参与疫苗政策和在英国不同地区提供疫苗的关键人物，并邀请他们参加研讨会，以便他们可以听到研究结果，并利用这些信息和计划来支持疫苗的高吸收。

项目成果

National survey of attitudes towards and intentions to vaccinate against COVID-19: implications for communications.

• DOI: 10.1136/bmjopen-2021-055085
• 发表时间: 2021-10-28
• 期刊: BMJ open
• 影响因子: 2.9
• 作者: Stead M;Jessop C;Angus K;Bedford H;Ussher M;Ford A;Eadie D;MacGregor A;Hunt K;MacKintosh AM
• 通讯作者: MacKintosh AM

A "step too far" or "perfect sense"? A qualitative study of British adults' views on mandating COVID-19 vaccination and vaccine passports

是“太过分了”还是“完美的感觉”？

• DOI: 10.1101/2022.02.07.22270458
• 发表时间: 2022
• 作者: Stead M